- Reuters via Yahoo FinanceOct 07 14:00 PM
The U.S. Supreme Court on Monday declined to hear Acorda Therapeutics Inc's appeal of a lower court ruling that allowed generic versions of its multiple sclerosis treatment Ampyra and caused ...
Xerostomia (Dry Mouth) Therapeutics Market Size Report Predicts Healthy Growth with Demand from Emerging SectorsMarket Watch4 days ago
Local and General Anesthesia Drugs Market Share Of USD 4.9 Billion By 2022 Globally Driven by Growing Number of Surgical ProceduresMarket Watch7 days ago
- Reuters via Yahoo Finance7 days ago